Abiopharma

New Form 144 - BeOne Medicines Ltd. Filed: 2025-06-24 AccNo: 0001950047-25-004569 Size: 7 KB

New Form 4 - RAPT Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0001415889-25-018080 Size: 5 KB

New Form 4 - Blueprint Medicines Corp Filed: 2025-06-24 AccNo: 0001415889-25-018078 Size: 5 KB

New Form 144 - Legend Biotech Corp Filed: 2025-06-24 AccNo: 0001959173-25-004278 Size: 5 KB

New Form 4 - RAPT Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0001415889-25-018072 Size: 5 KB

New Form 8-K - InspireMD, Inc. Filed: 2025-06-24 AccNo: 0001641172-25-016293 Size: 4 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 4 - Blueprint Medicines Corp Filed: 2025-06-24 AccNo: 0001415889-25-018073 Size: 5 KB

New Form 4 - Blueprint Medicines Corp Filed: 2025-06-24 AccNo: 0001415889-25-018069 Size: 4 KB

New Form 4 - RAPT Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0001415889-25-018067 Size: 5 KB

New Form 4 - Blueprint Medicines Corp Filed: 2025-06-24 AccNo: 0001415889-25-018065 Size: 4 KB

New Form 4 - RAPT Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0001415889-25-018063 Size: 5 KB

New Form 4 - RAPT Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0001415889-25-018062 Size: 5 KB

New Form 4 - iRhythm Technologies, Inc. Filed: 2025-06-24 AccNo: 0001388658-25-000164 Size: 5 KB

Jaguar Health Announces Extension of the Maturity Date of its Convertible Promissory Notes from Recently Closed Bridge Financing to January 30, 2026

New Form 4 - Trinseo PLC Filed: 2025-06-24 AccNo: 0001415889-25-018055 Size: 6 KB